Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: Can we identify those who derive the highest benefit?

Authors

Dhruv Mahtta, Michael E. DeBakey VA Medical Center, USA.
Salim S. Virani, Baylor College of Medicine, USA.Follow

Document Type

Editorial

Department

Office of the Provost; Cardiology

Comments

This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

Journal of Medical Economics

DOI

10.1080/13696998.2020.1754228

Recommended Citation

Mahtta, D., Virani, S. S. (2020). Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: Can we identify those who derive the highest benefit?. Journal of Medical Economics, 23(7), 670-672.
Available at: https://ecommons.aku.edu/provost_office/584